We are live on ! Find out more
AEGR

Aegerion Pharmaceuticals
AEGR

Delisted

AEGR was delisted on the 29th of November, 2016.

Back to rankings

Fund managers haven’t disclosed any holdings of AEGR yet.

AEGR Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Aegerion Pharmaceuticals (AEGR) for Q4 2016, worth a combined $0 — down 100% from $84.5M a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of AEGR and 0 opened new positions — a net loss of 58 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Scopia Capital Management, exiting entirely with an estimated $16.9M sold.

  • 0 institutional investors held Aegerion Pharmaceuticals (AEGR) as of Q4 2016, down from 58 in Q3 2016.
  • Funds reported $0 of Aegerion Pharmaceuticals stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new Aegerion Pharmaceuticals positions in Q4 2016 and 58 closed out, a net change of -58 holders.
  • The largest Aegerion Pharmaceuticals seller in Q4 2016 was Scopia Capital Management, an estimated $16.9M sold.

Based on aggregated 13F filings for Q4 2016.